DLH (DLHC) Downgraded by Zacks Investment Research to “Hold”

Zacks Investment Research downgraded shares of DLH (NASDAQ:DLHC) from a buy rating to a hold rating in a research report released on Friday morning.

According to Zacks, “DLH Holdings Corp. serves clients throughout the United States as a full-service provider of healthcare, logistics, and technical support services to DoD and Federal agencies. Its healthcare delivery solutions include professional services, such as case management, health and injury assessment, critical care, medical/surgical, emergency room/trauma center, counseling, behavioral health and trauma brain injury, medical systems analysis, and medical logistics, and allied support services in the areas of MRI technology, diagnostic sonography, phlebotomy, dosimetry, physical therapy, and pharmaceuticals. The company’s logistics and technical services include program and project management, systems engineering and applicable information technology services, integrated logistics support, training, equipment and non-tactical vehicle operations and maintenance, and facilities and shipyard support services. DLH Holdings Corp., formerly known as TeamStaff, Inc., is headquartered in Atlanta, Georgia. “

Other equities research analysts have also recently issued reports about the stock. Canaccord Genuity restated a buy rating and set a $7.00 price objective on shares of DLH in a research note on Friday, October 13th. TheStreet upgraded shares of DLH from a c rating to a b- rating in a research note on Wednesday, November 1st. Two analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The company has a consensus rating of Buy and a consensus target price of $7.17.

Shares of DLH (DLHC) opened at $6.16 on Friday. DLH has a one year low of $4.10 and a one year high of $6.83. The firm has a market cap of $73.43, a PE ratio of 22.81 and a beta of 0.65.

In related news, major shareholder Wynnefield Partners Small Cap sold 150,000 shares of DLH stock in a transaction dated Tuesday, December 12th. The shares were sold at an average price of $6.15, for a total transaction of $922,500.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 21.60% of the stock is owned by insiders.

A number of institutional investors have recently modified their holdings of the business. Dimensional Fund Advisors LP bought a new stake in DLH in the third quarter worth about $121,000. Commonwealth Equity Services Inc bought a new stake in DLH in the third quarter worth about $2,342,000. Finally, Essex Investment Management Co. LLC raised its position in DLH by 149.2% in the third quarter. Essex Investment Management Co. LLC now owns 71,887 shares of the business services provider’s stock worth $466,000 after acquiring an additional 43,043 shares in the last quarter. Hedge funds and other institutional investors own 54.33% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “DLH (DLHC) Downgraded by Zacks Investment Research to “Hold”” was reported by Community Financial News and is the property of of Community Financial News. If you are reading this report on another website, it was copied illegally and reposted in violation of US and international copyright legislation. The correct version of this report can be accessed at https://www.com-unik.info/2018/01/06/dlh-dlhc-downgraded-by-zacks-investment-research-to-hold.html.

DLH Company Profile

DLH Holdings Corp. provides healthcare and social services in the United States. It offers defense and veterans’ health solutions, including case management, physical and behavioral health examinations, and medical administration and logistics services. The company also provides a range of human services and solutions, which consists of educational and environmental support services for the underserved children and youth comprising health, nutritional, parental, and behavioral services; and IT system architecture design, migration plan, and ongoing maintenance services.

What are top analysts saying about DLH? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for DLH and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit